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EXPLANATORY MEMORANDUM 
Subject: Proposal for a Council Decision concerning the conclusion of a 
Cooperation Agreement between the European Economic Community and 
the Kingdom of Norway in the field of medical and health research. 
By its Decision of 17 November 1987 (1), the Council adopted a research 
and development programme of the Community in the field of medical and 
health research (1987 to 1991). Article 7 of this Decision authorises 
the Commission to negotiate agreements with the non-member States 
participating in European cooperation in the field of scientific and 
technical research (COST) with a view to associate them wholly or partly 
with the programme. 
2. In the context o-f the implementation of the Framework Agreement for 
scientific and technical cooperation between the European Communities and 
the Kingdom of Norway, the conclusion of which on behalf of the EEC was 
approved by the Council Decision of 9 February 1987, Norway has expressed 
an interest in cooperating in some of the research targets of the 
above-mentioned orocramme. 
3. Comprehensive research and development activities in the field of 
medicine and health are carried out in Norway. Bearing in mind the 
scientific and technical importance of these activities and considering 
that cooperation with Norway in the field of medical and health research 
is likely to contribute effectively to the attainment of an optimum level 
of individual and public health, the Commission has negotiated a draft 
cooperation agreement with Norway. 
4. The draft agreement, which is annexed to the attached proposal for a 
Council decision, provides for: 
- cooperation for a period from 1 January 1989 to 31 December 1991 in 
the following reseach targets of the Community programme: 
.- AIDS (Target 1.2), 
- Age-related health problems (Target 1.3), 
Environment and life-style health problems (Target 1.4). 
- Health services research (Target II.2) 
The cooperation consists of the coordination of the activities which 
form part of the research programmes of Norway and of the Community. 
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- a financial contribution from Norway for the implementation of the 
coordination activities. This financial contribution is proportional 
to Norway's gross domestic product and covers coordination costs, 
management and operating expenditure and fellowships. 
- the enlargement of the f4anagement and Coordination Advisory Committee 
on medical and health research (CGC) and of the relevant Concerted 
Action Committees (COMACs) to include Norwegian representatives. 
5. In view of the nature of the cooperation, any additional expenditure paid 
from the Community budget (relevant budget heading 7311) resulting from 
the implementation of this draft agreement will be covered by Norway's 
financial contribution. 
The funds paid by Norway will be credited to the Community budget 
(relevant budget article 602). 
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Proposal for a 
COUNCIL DECISION 
concerning the conclusion of a Cooperation Agreement between the European 
Economic Community and the Kingdom of Norway in the field of medical and 
health research. 
THE COUNCIL OF THE EUROPEAN COMMUNITIES, 
Having regard to the Treaty establishing the European Economic Community, and 
in particular Article 130 Q (2) thereof. 
Having regard to the proposal from the Commission (1), 
In cooperation with the European Parliament (2), 
Having regard to the opinion of the Economic and Social Committee (3), 
WHEREAS by Decision 87/551/EEC (4), the Council adopted a research and 
development coordination programme of the European Economic Community in the 
field of medical and health research (1987 to 1991); whereas Article 7 of 
this Decision authorises the Commission to negotiate agreements with the 
non-member States participating in- European cooperation in the field of 
scientific and technical research (COST) with a view to associate them wholly 
or partly with this programme, 
(1) O.J. N° C 
(2) O.J. N° C 
(3) O.J. N° C 
(4) O.J. N° L 334, 24.11.1987, p. 20 
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WHEREAS by Decision 87/177/EEC (1), the Council approved the conclusion on 
behalf of the European Economic Community of the the Framework Agreement for 
scientific and technical cooperation between the European Communities and, 
among others, the Kingdom of Norway, 
WHEREAS the cooperation Agreement between the European Economic Community and 
the Kingdom of Norway in the field of medical and health research should be 
approved, 
HAS DECIDED AS FOLLOWS: 
Article 1 
The Cooperation Agreement between the European Economic Community and the 
Kingdom of Norway in the field of medical and health research, is hereby 
approved on behalf of the Community. 
The text of the Agreement is attached to this Decision. 
Article 2 
The President of the Council shall carry out the notification as provided for 
in Article 7 of the Agreement. 
Article 3 
The present Decision shall enter into force on the day following its 
publication in the Official Journal of the European Communities. 
Done at .... 
For the Council 
The President 
(1) O.J. N° L 71, 14.03.1987, p. 29 
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COOPERATION AGREEMENT 
BETWEEN 
THE EUROPEAN ECONOMIC COMMUNITY 
AND 
THE KINGDOM OF NORWAY 
IN THE FIELD OF 
MEDICAL AND HEALTH RESEARCH 
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COOPERATION AGREEMENT 
BETWEEN 
THE EUROPEAN ECONOMIC COMMUNITY 
AND 
THE KINGDOM OF NORWAY 
IN THE FIELD OF 
MEDICAL AND HEALTH RESEARCH 
THE EUROPEAN ECONOMIC COMMUNITY, hereinafter referred to as "the Community", 
and 
THE KINGDOM OF NORWAY, hereinafter referred to. as "Norway*, 
both hereinafter referred to as "the Contracting Parties", 
WHEREAS the Contracting Parties concluded a Framework Agreement for 
Scientific and Technical Cooperation which entered into force on 17 July 
1987; 
WHEREAS by its Decision of 17 November 1987, the Council of the European 
Communities, hereinafter referred to as "the Council", adopted a research and 
development coordination programme of the Community in the field of medical 
and health research (1987 to 1991) which includes, among others, research 
targets on AIDS, age-related health problems, environment and life-style 
related health problems and health services research; 
WHEREAS comprehensive research and development activities in the field of 
medical and health research are carried out in Norway; 
WHEREAS cooperation in the field of medical and health research is likely to 
contribute effectively to the attainment of an optimum level of individual 
and public health; 
WHEREAS the Member States of the Community and Norway intend, in accordance 
with the rules and procedures applicable to their national programmes, to 
carry out the research described in Annex A and are prepared to integrate 
such research into a process of coordination which they consider will be of 
mutual benefit; 
HAVE AGREED AS FOLLOWS 
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Article 1 
The Contracting Parties shall cooperate for a period from 1 January 1989 to 
31 December 1991 in the following research targets of the Community 
programme: 
- AIDS (Target 1.2) 
- Age-related health problems (Target 1.3) 
- Environment and life-style related health problems (Target 1.4) 
- Health services research (Target II.2) 
The research topics covered by this Agreement are outlined in Annex A. 
The cooperation shall consist of the coordination of those activities which 
form part of the research programmes of Norway and of the Community. 
Norway and the Member States of the Community shall remain entirely 
responsible for the research carried out by their national institutions or 
bodies. 
Article 2 
The Commission of the European Communities, hereinafter referred to as "the 
Commission", shall be responsible for the implementation of the coordination 
activities. 
It shall be assisted in its task by the Management and Coordination Advisory 
Committee on Medical and Health Research, hereinafter referred to as the 
"CGC", set up by Council Decision 84/338 (1). This CGC may be assisted by 
Concerted Action Committees (COMACs) composed of experts designated by the 
competent authorities of Member States of the Community. 
The CGC, together with those COMACs relevant to the research targets referred 
to in Article 1, shall be enlarged to include two representatives designated 
by Norway who may be assisted or replaced by one Norwegian expert. These 
representatives and/or experts shall attend meetings of the CGC and those 
COMACs for all items relevant to those research targets. 
Article 3 
The estimated financial contribution from the Community for the 
implementation of the coordination activities covered by this Agreement shall 
be set according to the amount available each year in the general budget of 
the European Communities for appropriations covering commitments to meet 
financial obligations of the Commission relating to coordination costs, 
management and operating expenditure and fellowships. 
7T) OJ Nu L 177 of 04.07.1984, p. 25 
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The estimated financial contribution from Norway for the same costs and 
expenditures shall be proportional to the Community's contribution. The 
proportionality factor shall be given by the ratio between Norway's gross 
domestic product (GDP), at market prices, and the sum of gross domestic 
products, at market prices, of the Member States of the Community and Norway. 
This ratio shall be calculated on the basis of the latest available OECD 
statistical data. 
The total financial contributions from the Contracting Parties for the period 
referred to in Article 1 are estimated to amount to: 
- 24,190,000 Ecu from the Community 
470,979 Ecu from Norway 
The Ecu is that defined by the Council Regulation (EEC) No 3180/78 of 18 
December 1978 changing the value of the unit of account used by the European 
Monetary Cooperation Fund (1), as amended by Regulation (EEC) No 2626/84 (2). 
The rules governing the financial contribution from Norway are set out in 
Annex B. 
Article 4 
During the course of its third year, the Commission shall evaluate the 
programme, having regard to the objectives of the research targets referred 
to in Article 1. As a result of this evaluation, the Commission may, after 
the CGC has been consulted, submit to the Council a proposal for a revision 
affecting some or all of these research targets. Norway shall be informed of 
the results of this evaluation and of any possible revision. 
Article 5 
The Member States of the Community, Norway and the Commission shall regularly 
exchange all useful information concerning the execution of the research 
subjects covered by this Agreement. The Member States of the Community and 
Norway shall provide the Commission with all information necessary for 
coordination purposes. They shall also endeavour to provide the Commission 
with information on similar research planned or carried out by bodies which 
are not under their authority. Any information shall be treated as 
confidential if so requested by the party which provides it. 
On completion of the coordination activities covered by this Agreement, the 
Commission, in agreement with the CGC, shall send to the Member States of the 
Community, the European Parliament and Norway a summary report on the 
implementation and results of the research. 
Article 6 
This Agreement shall apply, on the one hand, to the territories in which the 
Treaty establishing the European Economic Community is applied and under the 
conditions laid down in that Treaty and, on the other hand, to the territory 
of the Kingdom of Norway. 
T T ) O J Nu L 379 of 30.12.1978, p. 1 
(2) 0J N° L 247 of 16.09.1984, p. 1 
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Article 7 
This Agreement shall be approved by the Contracting Parties in accordance 
with their existing procedures. It shall enter into force on the date on 
which the Contracting Parties have notified each other of the completion of 
the procedures necessary for this purpose. 
Article 8 
1. This Agreement is concluded for the period referred to in Article 1. 
Should the Community revise the Community programme, the Agreement may be 
renegotiated or terminated under mutually agreed conditions. Norway 
shall be notified of the exact content of the revised programme within 
one week after its adoption by the Community. The Contracting Parties 
shall notify each other within three months after the Community decision 
has been adopted if a termination of the Agreement is envisaged. 
2. Whenever a decision on the Community programme is taken by the Community, 
Annexes A and B shall be amended in accordance with the Community's 
decision, unless otherwise agreed upon by the Contracting Parties. 
3. Excepted as provided in paragraph 1 of this Article, either Contracting 
Party may at any time terminate this Agreement with 6 months' notice. 
Article 9 
The Annexes A and B to this Agreement shall be an integral part thereof. 
Article 10 
This Agreement shall be drawn up in duplicate in the Danish, Dutch, English, 
French, German, Greek, Italian, Portuguese, Spanish and Norwegian languages, 
each of these texts being equally authentic. 
Done at 
For the Council 
of the European Communities 
For the Kingdom of Norway 
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ANNEX A 
RESEARCH TOPICS COVERED BY THE AGREEMENT 
Target 1.2 - AIDS: 
Area 1.2.1 
Area 1.2.2 
Area 1.2.3 
Disease control and prevention 
Viro-immunological research 
Clinical research 
Target 1.3 - AGE-RELATED HEALTH PROBLEMS: 
Area 1.3.1 
Area 1.3.2 
Area 1.3.3 
Reproduction 
Ageing and diseases 
Disabilities 
Target 1.4 - ENVIRONMENT AND LIFE-STYLE HEALTH PROBLEMS: 
Area 1.4.1 
Area 1.4.2 
Area 1.4.3 
Area 1.4.4 
Breakdown in human adaption 
Nutrition 
Consumption of illicit drugs 
Infections 
Target II.2 - HEALTH SERVICES RESEARCH: (1) 
Area II.2.1 
Area II.2.2 
Area II.2.3 
Area II.2.4 
Research on prevention 
Research on care delivery systems 
Research on health care organisation 
Health technology assessment 
(1) The following actions will be carried out through seminars, studies and 
exchange of personnel for training purposes: 
- Evaluation of integrated non-communicable diseases prevention and 
control programmes (foreseen in Area II.2.1) 
- Comprehensive community care of the mentally ill (foreseen in Area 
II.2.2) 
- Health care planning and organisation (foreseen in Area II.2.3) 
Evaluation of clinical practive in hospitals (foreseen in Area 
II.2.3). 
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ANNEX B 
FINANCING RULES 
Article 1 
These provisions lay down the financing rules for Norway referred to in 
Article 3 of the Agreement. 
Article 2 
At the beginning of each year, or - in accordance with Article 8 of the 
Agreement - whenever the Community programme is revised so as to involve an 
increase in the amount estimated to be necessary for its implementation, the 
Commission shall send to Norway a call for funds corresponding to its share 
of the annual costs under the Agreement. 
This contribution shall be expressed both in Ecu and in the Norwegian 
currency. The value .in Norwegian currency of the contribution in Ecu shall 
be determined on the date of the call for funds. 
The travel costs of Norwegian representatives and experts deriving from their 
participation in the work of the CGC and COMACs referred to in Article 2 of 
the Agreement, shall be reimbursed by the Commission in accordance with the 
procedures currently in force for the representatives and experts of the 
Member States of the Community on the due date. The rate shall be increased 
by 0.25 of a percentage point for each month of delay. 
Norway shall pay its contribution to the annual costs under the Agreement at 
the beginning of each year and at the latest three months after the call for 
funds is sent. Any delay in the payment of the contribution shall give rise 
to the payment of interest by Norway at a rate equal to the highest discount 
rate in force in the Member States of the Community on the due date. The rate 
shall be increased by 0.25 of a percentage point for each month of delay. 
The increased rate shall be applied to the entire period of delay. However, 
this interest shall be payable only if the contribution is paid more than 
three months after a call for funds has been made by the Commission. 
Article 3 
The funds paid by Norway shall be credited to the four research targets as 
budget receipts allocated to an appropriate heading in the statement of 
revenue of the general budget of the European Communities. 
Article 4 
The provisional timetable for the costs referred to in Article 3 of the 
Agreement are appended hereto. 
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Article 5 
The Financial Regulations in force applicable to the general budget of the 
European Communities shall apply to the management of the appropriations. 
Art icle 6 
At the end of each year, a statement of appropriations for the four research 
targets shall be prepared and transmitted to Norway for information. 
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PROVISIONAL TIMETABLE FOR THE COSTS RELATING TO THE RESEARCH TARGETS (ECU) 
Budget heading 7311 "Medical and Health research" (appropriations for commitments) 
I | 1987 | 1988 | 1989 | 1990 | 1991 | TOTAL | 
| I. Initial estimate I I I I I I I 
| of expenditure | j j j | | I 
I - Target 1.2 | 2,160,000 | 3,500,000 | 4,000,000 | 3,340,000 | 1,000,000 | 14,000,000* | 
I - Target 1.3 j 580,000 j 1,670,000 | 2,200,000 | 2,400,000 | 2,150,000 | 9,000,000 | 
I - Target 1.4 | 250,000 | 1,350,000 | 1,650,000 | 1,400,000 | 850,000 | 5,500,000 | 
I - Target II.2 j 225,000 | 1,575,000 | 2,550,000 | 1,650,000 | 1,000,000 | 7,000,000 I 
I Total | 3,215,000 | 8,095,000 | 10,400,000 | 8,790,000 | 5,000,000 | 35,500,000 | 
| II. Revised estimate of j | | | | | I | expenditure taking into I I I I I I I | account the Cooperation | | | | I I I | Agreement with Norway | | | | I I I 
| - Target 1.2 | 2,160,000 | 3,500,000 | 4,077,880 | 3,405,030 | 1,019,470 | 14,162,380* | 
I - Target 1.3 | 580,000 | 1,670,000 j 2,242,834 | 2,446,728 | 2,191,860 | 9,131,422 | | - Target 1.4 | 250,000 j 1,350,000 | 1,682,126 | 1,427,257 | 866,550 | 5,575,933 | 
I - Target II.2 j 225,000 | 1,575,000 | 2,599,649 | 1,682,125 | 1,019,470 | 7,101,244 | 
I Total | 3,215,000 | 8,095,000 | 10,602,489 | 8,961,140 | 5,097,350 | 35,970,979 | 
| III. Difference between II and | I I I ! I I 
j and I to be covered by | 0 | 0 j 202,489 | 171,140 | 97,350 i 470,979* j | Norway's contribution | | | I I I I 
* Including support for "centralized facilities" for primates 
FICHE 0'IMPACT SUR LA COMPETITIVITE ET L'EMPLOI 
Ce projet a trait à une décision du Conseil concernant la conclusion d'un 
accord de coopération entre la CEE et la Norvège dans le domaine de la 
recherche médicale et sanitaire. 
En tant que tel, ce projet peut avoir un impact positif sur les PME, dans la 
mesure où il constitue un instrument facilitant l'accès à la connaissance et 
à l'échange d'expériences. 
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